Redcare Pharmacy stock: results on October 29, 2026, slightly lower pre-market
Published on 10/26/2026 at 07:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCalendar dates and opening indication
- The company’s next interim disclosure is scheduled for October 29, 2026.
- A virtual Baader Bank NDR is scheduled for November 2, 2026.
- Redcare Pharmacy stock trades pre-market at EUR 77.48 at 7:57 a.m. CET at Lang & Schwarz on October 26, 2026, 0.54 percent below the Xetra close of October 23, 2026.
Redcare Pharmacy’s investor-relations calendar lists its Q3 2026 interim statement for October 29, 2026, according to Redcare Pharmacy investor relations. Redcare Pharmacy stock trades pre-market at EUR 77.48 at 7:57 a.m. CET at Lang & Schwarz on October 26, 2026, 0.54 percent below the Xetra close of October 23, 2026 (EUR 77.90).
Upcoming company calendar
The scheduled Q3 interim statement will be accompanied by an analyst and investor conference, the company’s calendar says. The same calendar lists a virtual Baader Bank NDR for November 2, 2026; both dates are published by Redcare Pharmacy investor relations.
Ahead of the Xetra open
The pre-market indication is EUR 0.42 below the reference close. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.
Business and upcoming dates
Redcare Pharmacy investor relations describes the company as an online pharmacy selling prescription and nonprescription medicines through e-commerce in Europe. Its calendar also lists the November 2, 2026, virtual Baader Bank NDR. Market context: Market report AEX.
